SEOM clinical guidelines for the treatment of head and neck cancer (HNC) 2013
Authors:
- 27 August 2013
- journal article
- practice guideline
- Published by Springer Nature in Clinical and Translational Oncology
- Vol. 15 (12) , 1018-1024
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- Radiotherapy plus cetuximab for locoregionally advanced head and neck cancer: 5-year survival data from a phase 3 randomised trial, and relation between cetuximab-induced rash and survivalThe Lancet Oncology, 2010
- Larynx Preservation Clinical Trial Design: Key Issues and Recommendations—A Consensus Panel SummaryInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2009
- Platinum-Based Chemotherapy plus Cetuximab in Head and Neck CancerNew England Journal of Medicine, 2008
- Cisplatin, Fluorouracil, and Docetaxel in Unresectable Head and Neck CancerNew England Journal of Medicine, 2007
- Cisplatin and Fluorouracil Alone or with Docetaxel in Head and Neck CancerNew England Journal of Medicine, 2007
- Postoperative chemoradiotherapy for advanced squamous cell carcinoma of the head and neck: A systematic review with meta‐analysisHead & Neck, 2006
- Radiotherapy plus Cetuximab for Squamous-Cell Carcinoma of the Head and NeckNew England Journal of Medicine, 2006
- Phase III Study Comparing Cisplatin Plus Fluorouracil to Paclitaxel, Cisplatin, and Fluorouracil Induction Chemotherapy Followed by Chemoradiotherapy in Locally Advanced Head and Neck CancerJournal of Clinical Oncology, 2005
- Concurrent Chemotherapy and Radiotherapy for Organ Preservation in Advanced Laryngeal CancerNew England Journal of Medicine, 2003
- Induction Chemotherapy plus Radiation Compared with Surgery plus Radiation in Patients with Advanced Laryngeal CancerNew England Journal of Medicine, 1991